Document is current
Any future updates will be listed below
-
Authors
Henning, Nathaniel J.
Boike, Lydia
Spradlin, Jessica N. https://orcid.org/0000-0001-7278-6645
Ward, Carl C. https://orcid.org/0000-0002-1188-4839
Liu, Gang
Zhang, Erika
Belcher, Bridget P. https://orcid.org/0000-0003-4837-9390
Brittain, Scott M.
Hesse, Matthew J. https://orcid.org/0000-0002-4759-5086
Dovala, Dustin
McGregor, Lynn M. https://orcid.org/0000-0003-4310-2384
Valdez Misiolek, Rachel
Plasschaert, Lindsey W.
Rowlands, David J.
Wang, Feng https://orcid.org/0000-0002-4322-2127
Frank, Andreas O. https://orcid.org/0000-0002-2330-3974
Fuller, Daniel
Estes, Abigail R.
Randal, Katelyn L.
Panidapu, Anoohya
McKenna, Jeffrey M. https://orcid.org/0000-0002-2978-5652
Tallarico, John A. https://orcid.org/0000-0002-8040-8422
Schirle, Markus https://orcid.org/0000-0003-4933-2623
Nomura, Daniel K. https://orcid.org/0000-0003-1614-8360
-
Funding
Funding for this research was provided by:
Novartis Institutes for BioMedical ResearchMark Foundation for Cancer Research
National Institutes of HealthMark Foundation for Cancer ResearchNovartis Institutes for BioMedical ResearchNational Science Foundation
- License Information
-
More Information
Article History
Received: 30 April 2021
Accepted: 9 January 2022
First Online: 24 February 2022
Competing interests
: J.A.T., J.M.M., L.M.M., D.D., M.H., M.S., S.M.B., G.L., R.V.M., L.W.P., D.J.R., F.W., A.O.F. and D.F. are employees of Novartis Institutes for BioMedical Research. This study was funded by the Novartis Institutes for BioMedical Research and the Novartis-Berkeley Center for Proteomics and Chemistry Technologies. D.K.N. is a cofounder, shareholder and adviser for Frontier Medicines and Vicinitas Therapeutics. D.K.N. is also on the scientific advisory board of The Mark Foundation for Cancer Research and Photys Therapeutics.
